MedPath
FDA Approval

Valganciclovir

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 26, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Valganciclovir(450 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Strides Pharma, Inc

Strides Pharma Science Limited

Strides Pharma Global Pte. Ltd.

118344504

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valganciclovir

Product Details

NDC Product Code
64380-153
Application Number
ANDA200790
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 26, 2024
Code: 4P3T9QF9NZClass: ACTIRQuantity: 450 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
POLYETHYLENE GLYCOL 4000Inactive
Code: 4R4HFI6D95Class: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath